journal article·2020-06-24Open access

Multiresponsive Hybrid Microparticles for Stimuli-Responsive Delivery of Bioactive Compounds

Sergei S. Vlasov, Pavel S. Postnikov, Mikhail V. Belousov, Sergei V. Krivoshchekov, Mekhman S. Yusubov, Artem M. Guryev, Antonio Di Martino

Applied Sciences· Volume 10· Issue 12

Abstract

Hybrid microparticles based on an iron core and an amphiphilic polymeric shell have been prepared to respond simultaneously to magnetic and ultrasonic fields and variation in the surrounding pH to trigger and modulate the delivery of doxorubicin. The microparticles have been developed in four steps: (i) synthesis of the iron core; (ii) surface modification of the core; (iii) conjugation with the amphiphilic poly(lactic acid)-grafted chitosan; and (iv) doxorubicin loading. The particles demonstrate spherical shape, a size in the range of 1–3 µm and surface charge that is tuneable by changing the pH of the environment. The microparticles demonstrate good stability in simulated physiological solutions and are able to hold up to 400 µg of doxorubicin per mg of dried particles. The response to ultrasound and the changes in the shell structure during exposure to different pH levels allows the control of the burst intensity and release rate of the payload. Additionally, the magnetic response of the iron core is preserved despite the polymer coat. In vitro cytotoxicity tests performed on fibroblast NIH/3T3 demonstrate a reduction in the cell viability after administration of doxorubicin-loaded microparticles compared to the administration of free doxorubicin. The application of ultrasound causes a burst in the release of the doxorubicin from the carrier, causing a decrease in cell viability. The microparticles demonstrate in vitro cytocompatibility and hemocompatibility at concentrations of up to 50 and 60 µg/mL, respectively.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Polymer Nanocomposite Synthesis and Irradiation · Chemotherapy-induced cardiotoxicity and mitigation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Central Scientific Research Laboratory, Siberian State Medical University (SibSMU), 634050 Tomsk, Russia

Research School of Chemistry & Applied Biomedical Sciences, Tomsk Polytechnic University, Lenin Av. 30, 634050 Tomsk, Russia

Department of Solid State Engineering, University of Chemistry and Technology, 16628 Prague, Czech Republic

Department of Pharmaceutical Analysis, Siberian State Medical University (SibSMU), 634050 Tomsk, Russia

Funding

Ministry of Science and Higher Education of the Russian Federation

References (42)

Show source-provided references
1. Stimuli-responsive nanocarriers for drug delivery10.1038/nmat3776 ↗
2. Stimuli-sensitive nanopreparations for combination cancer therapy10.1016/j.jconrel.2014.05.002 ↗
4. The significance of intertumor and intratumor heterogeneity in liver cancer10.1038/emm.2017.165 ↗
5. Intratumor heterogeneity in epigenetic patterns10.1016/j.semcancer.2018.01.010 ↗
6. Enzyme-responsive nanoparticles for drug release and diagnostics10.1016/j.addr.2012.01.002 ↗
7. Hyperthermia: Role and risk factor for cancer treatment
8. Stimuli-responsive cross-linked micelles for on-demand drug delivery against cancers10.1016/j.addr.2013.09.008 ↗
9. Hybrid core/shell microparticles and their use for understanding biological processes10.1016/j.jcis.2015.06.040 ↗
10. Iron oxide-based superparamagnetic polymeric nanomaterials: Design, preparation, and biomedical application10.1016/j.progpolymsci.2010.08.005 ↗
11. Evaluation of chitosan derivative microparticles encapsulating superparamagnetic Iron oxide and doxorubicin as a pH-sensitive delivery carrier in hepatic carcinoma treatment: An in vitro comparison study10.3389/fphar.2018.01025 ↗
12. Organic-inorganic hybrid nanoparticles controlled delivery system for anticancer drugs10.1016/j.ijpharm.2017.04.061 ↗
13. Application of near-infrared dyes for tumor imaging, photothermal, and photodynamic therapies10.1002/jps.23356 ↗
14. Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers10.1002/jps.20745 ↗
15. Chitosan (or alginate)-coated iron oxide nanoparticles: A comparative study10.1016/j.colsurfa.2014.12.031 ↗
16. Polymer architecture and drug delivery10.1007/s11095-005-9046-2 ↗
17. Molecular engineering solutions for therapeutic peptide delivery10.1039/C7CS00536A ↗
18. Targeted drug delivery with polymers and magnetic nanoparticles: Covalent and noncovalent approaches, release control, and clinical studies10.1021/acs.chemrev.5b00589 ↗
19. Magnetorheology of core–shell structured carbonyl iron/polystyrene foam microparticles suspension with enhanced stability10.1021/acs.macromol.5b01430 ↗
20. Thermal and magnetic properties of chitosan-iron oxide nanoparticles10.1016/j.carbpol.2016.04.123 ↗
21. Doxorubicin: An update on anticancer molecular action, toxicity and novel drug delivery systems10.1111/j.2042-7158.2012.01567.x ↗
22. Doxorubicin-induced cardiomyopathy10.1056/NEJM199809243391307 ↗
23. Multidrug resistance mediated by MRP1 gene overexpression in breast cancer patients10.1080/07357900802173562 ↗
24. Amphiphilic chitosan-grafted-functionalized polylactic acid based nanoparticles as a delivery system for doxorubicin and temozolomide co-therapy10.1016/j.ijpharm.2014.08.014 ↗
25. The convenient preparation of stable aryl-coated zerovalent iron nanoparticles10.3762/bjnano.6.121 ↗
26. Synthesis and characterization of micron-sized monodisperse superparamagnetic polymer particles with amino groups10.1002/pola.20803 ↗
27. Multidrug delivery system based on polysaccharide nanocomplexes for controlled delivery of a combination of chemotherapeutics10.1016/j.jddst.2019.01.003 ↗
28. Modification and characterization of polystyrene-based magnetic microspheres and comparison with albumin-based magnetic microspheres10.1016/S0304-8853(00)01223-3 ↗
29. Doxorubicin loaded PEG-b-poly (4-vinylbenzylphosphonate) coated magnetic iron oxide nanoparticles for targeted drug delivery10.1016/j.jmmm.2015.02.078 ↗
30. Iron oxide nanoparticles for magnetically-guided and magnetically-responsive drug delivery10.3390/ijms16048070 ↗
31. Reduced aggregation and sedimentation of zero-valent iron nanoparticles in the presence of guar gum10.1016/j.jcis.2008.04.064 ↗
32. Surface modification of polymers by reduction of diazonium salts: Polymethylmethacrylate as an example10.1039/C3TC31492H ↗
33. Ultrasound-mediated drug delivery10.1111/odi.12501 ↗
34. Overcoming MDR by ultrasound-induced hyperthermia and P-glycoprotein modulation10.1006/bbrc.2001.5938 ↗
35. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption10.1016/j.jconrel.2016.10.011 ↗
36. Understanding ultrasound induced sonoporation: Definitions and underlying mechanisms10.1016/j.addr.2013.11.008 ↗
37. External-stimuli responsive systems for cancer theranostic10.1016/j.ajps.2016.06.001 ↗
38. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery10.1016/j.ejps.2014.05.021 ↗
39. Chitosan-based nanoparticles as drug delivery systems for doxorubicin: Optimization and modelling10.1016/j.carbpol.2016.03.028 ↗
40. Nanotechnology for the biologist10.1189/jlb.0205074 ↗
41. PEI-based vesicle-polymer hybrid gene delivery system with improved biocompatibility10.1016/j.ijpharm.2003.12.029 ↗
42. Method for analysis of nanoparticle hemolytic properties in vitro10.1021/nl0805615 ↗